招聘
Mainz, Germany | full time | Job ID: 11159
About the Role:
We are looking for a detail-oriented Integration Subject Matter Expert (m/w/d) with a strong finance focus to support Business and IT Leads within the Integration Management workstream. In this role, you will drive the integration of finance processes and systems throughout the SAP S/4HANA project phases and ensure seamless operations post-implementation. Join us in delivering sustainable solutions that align with BioNTech’s mission to improve lives through science and technology.
Your Contribution:
- Provide expert guidance on finance process integration and technical interfaces between SAP S/4HANA and other systems
- Collaborate with Business and IT Leads to translate finance requirements into integration solutions
- Support design, development, testing, and troubleshooting of finance-related integration scenarios during project phases and ongoing operations
- Review and validate integration documentation, data flows, and configurations related to finance processes
- Participate in workshops, testing cycles (unit, integration, user acceptance), and validations across project and post-go-live activities
- Ensure smooth end-to-end finance integration by liaising with cross-functional teams
A Good Match:
- Proven experience (5+ years preferred) in finance process integration within SAP environments, including SAP S/4HANA
- Experience throughout the whole pharma end-to-end process required, focus on finance or material area would be beneficial
- Previous experience in the pharmaceutical industry; familiarity with regulatory requirements (e.g., SOX) is an advantage
- Analytical mindset with problem-solving skills for project delivery and operational support
- Excellent documentation, communication, and collaboration skills across business and IT teams
- Fluent English communication skills (written and spoken); self-motivated with the ability to work independently
Apply now
- We look forward to receiving your application!
Apply to our Mainz, Germany location by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 11159 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
相似职位

Program Manager- Weapon Systems Program Execution
BAE Systems · Louisville, Kentucky, United States

Project Manager
JLL · Singapore

Construction Manager, Data Center Construction
Amazon · Shreveport, LA, USA

Program Manager – Exam Management - Vice President
JPMorgan Chase · Plano, TX, United States, US

Program Manager, Transformation
Google ·
关于BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
员工数
Mainz that develops immunotherapies
总部位置
$21.7B
企业估值
评价
4.0
10条评价
工作生活平衡
2.5
薪酬
3.8
企业文化
4.2
职业发展
3.5
管理层
3.2
75%
推荐给朋友
优点
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
缺点
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
薪资范围
70个数据点
L4
M3
M4
M5
M6
Mid/L4
Intern
L4 · Product Manager
0份报告
$81,002
年薪总额
基本工资
-
股票
-
奖金
-
$68,851
$93,153
面试经验
1次面试
难度
3.0
/ 5
时长
14-28周
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
常见问题
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
新闻动态
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
3d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
5d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
1w ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
1w ago